These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17094926)

  • 21. Curcumin as a putative antidepressant.
    Seo HJ; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU
    Expert Rev Neurother; 2015 Mar; 15(3):269-80. PubMed ID: 25644944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [7th Congress of the Collegium Internationale Neuro-Psychopharmacologicum].
    Vinar O; Vojtĕchovský M
    Cesk Psychiatr; 1971 Jun; 67(3):181-3. PubMed ID: 5087322
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial.
    Sarubin N; Nothdurfter C; Schüle C; Lieb M; Uhr M; Born C; Zimmermannc R; Bühner M; Konopka K; Rupprecht R; Baghai TC
    J Psychiatr Res; 2014 Jun; 53():76-83. PubMed ID: 24655586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of antidepressants: similar but different.
    Matthews PR
    Int J Neuropsychopharmacol; 2011 Nov; 14(10):1433-4; author reply 1435-7. PubMed ID: 21489347
    [No Abstract]   [Full Text] [Related]  

  • 25. [The present state of drug treatment of depression].
    Kielholz P
    Nervenarzt; 1966 Mar; 37(3):118-21. PubMed ID: 5965686
    [No Abstract]   [Full Text] [Related]  

  • 26. Not fade away: the HPA axis and depression.
    Cowen PJ
    Psychol Med; 2010 Jan; 40(1):1-4. PubMed ID: 19335939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.
    Correll CU; Kratochvil CJ; March JS
    J Clin Psychiatry; 2011 May; 72(5):655-70. PubMed ID: 21658348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proceedings of the 15th Collegium Internationale Neuro-Psychopharmacologicum Congress. Puerto Rico, U.S.A., December 14-17, 1986.
    Clin Neuropharmacol; 1986; 9 Suppl 4():1-584. PubMed ID: 3567935
    [No Abstract]   [Full Text] [Related]  

  • 29. Updates and trends in the treatment of major depressive disorder.
    Papakostas GI; Ionescu DF
    J Clin Psychiatry; 2014 Dec; 75(12):1419-21. PubMed ID: 25551237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic and therapeutic strategies in treatment-resistant depression. Introduction and clinical presentations.
    O'Reardon JP
    CNS Spectr; 2009 Mar; 14(3 Suppl 4):4-6. PubMed ID: 19407713
    [No Abstract]   [Full Text] [Related]  

  • 31. Residual symptoms in depression an emerging therapeutic concept.
    Sonino N; Fava GA
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 May; 26(4):763-70. PubMed ID: 12188108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Psychopharmacology of anxiety and depression: Historical aspects, current treatments and perspectives].
    Javelot H
    Ann Pharm Fr; 2016 Mar; 74(2):93-118. PubMed ID: 26472602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressant Treatment Duration in Pediatric Depressive and Anxiety Disorders: How Long is Long Enough?
    Hathaway EE; Walkup JT; Strawn JR
    Curr Probl Pediatr Adolesc Health Care; 2018 Feb; 48(2):31-39. PubMed ID: 29337001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A history of the Collegium Internationale Neuro-Psychopharmacologicum (1957-2004).
    Ban TA
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):599-616. PubMed ID: 16564121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current issues in the treatment of depression in bipolar disorder patients.
    Janowsky DS
    Curr Psychiatry Rep; 2005 Dec; 7(6):485-6. PubMed ID: 16318828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On the treatment of depression with a new dibenzodiazepine derivative].
    Schigutt R; Suchanek-Fröhlich H
    Wien Klin Wochenschr; 1965 Sep; 77(35):584-6. PubMed ID: 5858768
    [No Abstract]   [Full Text] [Related]  

  • 37. Low dose of caffeine enhances the efficacy of antidepressants in major depressive disorder and the underlying neural substrates.
    Liu QS; Deng R; Fan Y; Li K; Meng F; Li X; Liu R
    Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28054436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined treatments for depression as for other medical disorders.
    Blier P
    Am J Psychiatry; 2012 Jan; 169(1):95; author reply 95-6. PubMed ID: 22223012
    [No Abstract]   [Full Text] [Related]  

  • 39. Preventing recurrent depression: long-term treatment for major depressive disorder.
    J Clin Psychiatry; 2007 Apr; 68(4):619-30. PubMed ID: 17474820
    [No Abstract]   [Full Text] [Related]  

  • 40. Cytokines: abnormalities in major depression and implications for pharmacological treatment.
    O'Brien SM; Scott LV; Dinan TG
    Hum Psychopharmacol; 2004 Aug; 19(6):397-403. PubMed ID: 15303243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.